ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

Athreya A. P.; Neavin D.; Carrillo-Roa T.; Frye M. A.; Skime M.; Rush A.; Bobo W. V.; Wang L.; Binder E.; Iyer R. K.; Weinshilboum R. M.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

【24h】

ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

机译：药物替代科学中的人工智力增强精神病学：对重大抑郁症患者的抗抑郁药物选择的个性化。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2019年第1期|共1页
作者
Athreya A. P.; Neavin D.; Carrillo-Roa T.; Frye M. A.; Skime M.; Rush A.; Bobo W. V.; Wang L.; Binder E.; Iyer R. K.; Weinshilboum R. M.;
展开▼
作者单位

Univ Illinois Urbana IL USA;

Mayo Clin Rochester MN USA;

Max Planck Inst Psychiat Munich Germany;

Mayo Clin Rochester MN USA;

Mayo Clin Rochester MN USA;

Duke Univ Sch Med Durham NC USA;

Mayo Clin Jacksonville FL 32224 USA;

Mayo Clin Rochester MN USA;

Max Planck Inst Psychiat Munich Germany;

Univ Illinois Urbana IL USA;

Mayo Clin Rochester MN USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. [J] . Athreya A. P., Neavin D., Carrillo-Roa T., Clinical Pharmacology and Therapeutics . 2019,第Suppla1期

机译：药物替代科学中的人工智力增强精神病学：对重大抑郁症患者的抗抑郁药物选择的个性化。
2. A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial [J] . Changsu Han, Sheng-Min Wang, Won-Myong Bahk, Clinical Psychopharmacology and Neuroscience . 2018,第4期

机译：具有严重抑郁症患者的基于药物基因组学的抗抑郁药治疗：一项为期8周的随机单盲临床试验的结果
3. The effect of adding psychodynamic therapy to antidepressants in patients with major depressive disorder. A systematic review of randomized clinical trials with meta-analyses and trial sequential analyses [J] . JakobsenJ.C., HansenJ.L., SimonsenE., Journal of affective disorders . 2012,第1a3期

机译：对重度抑郁症患者的抗抑郁药加心理动力学治疗的效果。通过荟萃分析和试验顺序分析对随机临床试验进行系统评价
4. Emotional Detection of Patients Major Depressive Disorder in Medical Diagnosis [C] . Mahasak Ketcham, Manussawee Piyaneeranart, Thittaporn Ganokratanaa International Conference on Signal-Image Technology and Internet-Based Systems . 2018

机译：情绪低下患者的重大抑郁症的医学诊断
5. Self-reported physician prescribing behavior and factors related to antidepressant prescribing to children and adolescents with major depressive disorder. [D] . Pfalzgraf, Andrea R. 2009

机译：自我报告的医生对患有严重抑郁症的儿童和青少年开处方的行为和与抗抑郁药有关的因素。
6. Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week Randomized Single-blinded Clinical Trial [O] . Changsu Han, Sheng-Min Wang, Won-Myong Bahk, 2020

机译：勘误：对主要抑郁症患者的药物基因组抗抑郁治疗：8周随机单盲临床试验的结果
7. A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial [O] . Changsu Han, Sheng-Min Wang, Won-Myong Bahk, 2018

机译：针对主要抑郁症患者的药物基因组抗抑郁药治疗：8周，随机单盲临床试验的结果

ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

著录项

相似文献

相关主题

期刊订阅